CellWell record HH-0478
Shilajit extract reduces oxidative stress, inflammation, and bone loss to dose-dependently preserve bone mineral density in postmenopausal women with osteopenia: a randomized, double-blind, placebo-controlled trial
Pingali U, Nutalapati C
Phytomedicine ยท 2022
In plain language
Over 48 weeks, a standardized shilajit extract dose-dependently supported bone mineral density at the spine and hip in postmenopausal women, alongside favorable changes in oxidative-stress and bone-turnover markers.
- Design
- Randomized controlled trial
Cite this record: https://thecellwell.org/studies/HH-0478
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.